The Clinicopathologic Significance of p53 and BAF250a (ARID1A) Expression in Clear Cell Carcinoma of the Endometrium

被引：0
作者：
Fadare, O.
Gwin, K.
Desouki, M. M.
Crispens, M. A.
Jones, H. W., III
Khabele, D.
Mohammed, K.
Liang, S. X.
Zheng, W.
Hecht, J. L.
Parkash, V.
机构：
[1] Vanderbilt Univ, Nashville, TN USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] UPMC, Pittsburgh, PA USA
[4] N Shore LIJ, Nhp, NY USA
[5] Univ Arizona, Tucson, AZ USA
[6] Harvard Univ, Boston, MA 02115 USA
[7] Yale Univ, New Haven, CT USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1138
引用
收藏
页码：273A / 273A
页数：1
相关论文
共 50 条
[21]   LncRNA-GAS5 Inhibits Proliferation and Invasion of Ovarian Clear Cell Carcinoma via miR-221/ARID1A/BAF250a Axis [J].
Zhang, Jian ;
Yang, Zhongmei ;
Huang, Yu ;
Wang, Kana ;
Xie, Yao ;
Yang, Nian .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 :41-41
[22]   Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas [J].
Wiegand, Kimberly C. ;
Lee, Anna F. ;
Al-Agha, Osama M. ;
Chow, Christine ;
Kalloger, Steve E. ;
Scott, David W. ;
Steidl, Christian ;
Wiseman, Sam M. ;
Gascoyne, Randy D. ;
Gilks, Blake ;
Huntsman, David G. .
JOURNAL OF PATHOLOGY, 2011, 224 (03) :328-333
[23]   HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A [J].
Van Rechem, Capucine ;
Boulay, Gaylor ;
Leprince, Dominique .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 385 (04) :586-590
[24]   Significance of p53 expression in background endometrium in endometrial carcinoma [J].
Thuy Thi Nguyen ;
Toru Hachisuga ;
Rie Urabe ;
Tomoko Kurita ;
Seiji Kagami ;
Toshinori Kawagoe ;
Shohei Shimajiri ;
Kazuki Nabeshima .
Virchows Archiv, 2015, 466 :695-702
[25]   Significance of p53 expression in background endometrium in endometrial carcinoma [J].
Thuy Thi Nguyen ;
Hachisuga, Toru ;
Urabe, Rie ;
Kurita, Tomoko ;
Kagami, Seiji ;
Kawagoe, Toshinori ;
Shimajiri, Shohei ;
Nabeshima, Kazuki .
VIRCHOWS ARCHIV, 2015, 466 (06) :695-702
[26]   Clinicopathological Significance of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma [J].
Maeda, D. ;
Mao, T-L ;
Fukayama, M. ;
Wang, T-L ;
Shih, I-M .
MODERN PATHOLOGY, 2011, 24 :259A-259A
[27]   ARID1A MUTATION WITH LOSS OF PROTEIN EXPRESSION OF BAF250A MAY ACT AS AN EARLY EVENT IN THE TRANSFORMATION OF ENDOMETRIOSIS INTO OVARIAN CANCER [J].
Wu, C. H. ;
Lin, H. ;
Ou, Y. C. ;
Haung, C. C. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 :1720-1720
[28]   ARID1A MUTATION WITH LOSS OF PROTEIN EXPRESSION OF BAF250A MAY ACT AS AN EARLY EVENT IN THE TRANSFORMATION OF ENDOMETRIOSIS INTO OVARIAN CANCER [J].
Wu, C. H. ;
Lin, H. ;
Ou, Y. C. ;
Haung, C. C. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 :559-559
[29]   ARID1A expression in ovarian clear cell carcinoma with an adenofibromatous component [J].
Nishikimi, Kyoko ;
Kiyokawa, Takako ;
Tate, Shinichi ;
Iwamoto, Masami ;
Shozu, Makio .
HISTOPATHOLOGY, 2015, 67 (06) :866-871
[30]   Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma [J].
Maeda, Daichi ;
Mao, Tsui-Lien ;
Fukayama, Masashi ;
Nakagawa, Shunsuke ;
Yano, Tetsu ;
Taketani, Yuji ;
Shih, Ie-Ming .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (12) :5121-5129
12345